TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24427628

Group type: EXPERIMENTAL
Intervention: Lornoxicam
Number of subjects: 45

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 45
Study: 20804871

Group type: EXPERIMENTAL
Intervention: Calcitriol + Calcium
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Oral Calcium
Number of subjects: 706

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 706
Study: 18978624

Group type: EXPERIMENTAL
Intervention: Strength Training (ST), n = 9, 45-80% 1RM, 2-4 sets, 20-6 reps
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Circuit Training (CT), n = 10, 45-60% 1RM, 2-3 sets, 20-10 reps
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON), n = 9, no exercise
Number of subjects: 28
Study: 16463409

Group type: EXPERIMENTAL
Intervention: Chronic opioid use among subjects with rheumatoid arthritis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic opioid use among subjects with osteoarthritis, chronic low back pain, or ischemic heart disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-potency opioids prescribed for chronic users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prior use of psychiatric medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prior psychiatric diagnosis
Number of subjects: 0
Study: 15189630

Group type: EXPERIMENTAL
Intervention: Four-component model of procedural justice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11015127

Group type: EXPERIMENTAL
Intervention: Week 1 respiratory system resistance (Rrs) measurement
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Week 1 respiratory system compliance (Crs) measurement
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multiple logistic models including week 1 Rrs
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Throughout the 4-week study period
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Rrs results in prediction models
Number of subjects: 46
Study: 9174890

Group type: EXPERIMENTAL
Intervention: Split-thickness skin graft
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edlan-plasty with implants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kazanjian-plasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vestibuloplasty with keratinized grafts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Split-thickness skin graft from palate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Graft from palate
Number of subjects: 0
Study: 1606858

Group type: EXPERIMENTAL
Intervention: Slit-suction drainage
Number of subjects: 80

Group type: COMPARATOR
Intervention: Redon-suction drainage
Number of subjects: 80
Study: 30789079

Group type: EXPERIMENTAL
Intervention: Recruitment methods including word of mouth, email and website advertisements, printed posters, Facebook ads, and a 1-week newspaper ad campaign.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Gutbusters program (weight loss intervention).
Number of subjects: 102
Study: 29329442

Group type: EXPERIMENTAL
Intervention: Conventional Radiofrequency (CRF)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Pulsed Radiofrequency (PRF)
Number of subjects: 65
Study: 26428353

Group type: EXPERIMENTAL
Intervention: Gluten-free casein-free (GFCF) diet
Number of subjects: 105

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 105
Study: 23949160

Group type: EXPERIMENTAL
Intervention: WB‐EMS (n = 38)
Number of subjects: 76

Group type: COMPARATOR
Intervention: aCG (n = 38)
Number of subjects: 76
Study: 23276067

Group type: EXPERIMENTAL
Intervention: Preventive, family-oriented interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list controls
Number of subjects: 0
Study: 20518950

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg once daily
Number of subjects: 787

Group type: COMPARATOR
Intervention: Ibuprofen 600 mg three times daily
Number of subjects: 787
Study: 18090405

Group type: EXPERIMENTAL
Intervention: Continuous treatment with tenofovir/emtricitabine-based ART
Number of subjects: 16

Group type: COMPARATOR
Intervention: CD4 cell count-guided interruptions of tenofovir/emtricitabine-based ART
Number of subjects: 16
Study: 16889757

Group type: EXPERIMENTAL
Intervention: Mifepristone (7 days)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 12663301

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d as carbonate)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Attendance at > 50% of exercise sessions
Number of subjects: 144
Study: 15321088

Group type: EXPERIMENTAL
Intervention: Verbal plus written consent
Number of subjects: 82

Group type: COMPARATOR
Intervention: Verbal consent
Number of subjects: 82
Study: 8639015

Group type: COMPARATOR
Intervention: Usual Care Model
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Office Assisted Model
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Nutrition Center Model
Number of subjects: 930
Study: 1738214

Group type: EXPERIMENTAL
Intervention: Peptide enteral formula (PEF)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard enteral formula (SEF)
Number of subjects: 41
Study: 6427057

Group type: EXPERIMENTAL
Intervention: D100 (all nonprotein calories as dextrose)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: D25 (nonprotein calories as a combination of dextrose and lipid in a 1:3 ratio)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: D75 (nonprotein calories as a combination of dextrose and lipid in a 3:1 ratio)
Number of subjects: 20

Group type: COMPARATOR
Intervention: D100
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: D25
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: D75
Number of subjects: 20
Study: 31684015

Group type: EXPERIMENTAL
Intervention: High-fat, low-fiber meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fat, high-fiber meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fat meal with high-fiber cereal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-fat meal
Number of subjects: 10
Study: 30541594

Group type: EXPERIMENTAL
Intervention: Accelerated rule-out protocol using combined prehospital copeptin and in-hospital high sensitive troponin (hs-cTn)
Number of subjects: 4800

Group type: COMPARATOR
Intervention: Standard rule-out protocol using consecutive troponin measurements
Number of subjects: 4800
Study: 27732032

Group type: EXPERIMENTAL
Intervention: Circle (confidence interval) visualization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faded glyph (probability density function) visualization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combining 2 uncertain estimates of location
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visualization of uncertainty
Number of subjects: 0
Study: 24850754

Group type: EXPERIMENTAL
Intervention: Erythropoietin at 500 U/kg per week
Number of subjects: 131

Group type: COMPARATOR
Intervention: No treatment (control arm)
Number of subjects: 131
Study: 22133305

Group type: EXPERIMENTAL
Intervention: Active cannabis (THC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20636471

Group type: EXPERIMENTAL
Intervention: High-fidelity human simulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Videotaped vignettes
Number of subjects: 36
Study: 17496463

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg once daily
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Ramipril 10 mg once daily
Number of subjects: 1279
Study: 15186302

Group type: EXPERIMENTAL
Intervention: Montelukast 20 mg
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 11783681

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEi)
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: Opportunistic single dipstick test for protein, confirming 24-h urine test for protein, commencement of ACEi
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: ACEi treatment
Number of subjects: 20000

Group type: EXPERIMENTAL
Intervention: 24-h urine protein test
Number of subjects: 20000
Study: 9660339

Group type: EXPERIMENTAL
Intervention: Bioactive glass synthetic bone graft particles
Number of subjects: 16
Study: 7906329

Group type: EXPERIMENTAL
Intervention: Comfortex DeCube mattress
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard hospital mattress
Number of subjects: 44
Study: 2562546

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 65
Study: 132902

Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clindamycin hydrate hydrochloride
Number of subjects: 100
Study: 31640504

Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-stage estimator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G-estimator
Number of subjects: 0
Study: 31242517

Group type: EXPERIMENTAL
Intervention: PD1 inhibitor pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional chemotherapy (vinflunine, docetaxel, or paclitaxel)
Number of subjects: 0
Study: 27464970

Group type: EXPERIMENTAL
Intervention: Cixutumumab (20 mg/kg), Pemetrexed (500 mg/m2), Cisplatin (75 mg/m2)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control (Pemetrexed and Cisplatin)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Cixutumumab (20 mg/kg)
Number of subjects: 172
Study: 25645666

Group type: EXPERIMENTAL
Intervention: 90-year-old patient case
Number of subjects: 291

Group type: COMPARATOR
Intervention: 60-year-old patient case
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: 90-year-old patient case (surgeons)
Number of subjects: 291

Group type: COMPARATOR
Intervention: 90-year-old patient case (other consultants)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: 60-year-old patient case (anaesthetists)
Number of subjects: 291

Group type: COMPARATOR
Intervention: 60-year-old patient case (other consultants)
Number of subjects: 291
Study: 23456778

Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/day)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Chemotherapy (gemcitabine‐carboplatin)
Number of subjects: 154
Study: 22046851

Group type: EXPERIMENTAL
Intervention: Breast cancer education sessions offered in beauty salons
Number of subjects: 984

Group type: COMPARATOR
Intervention: Diabetes education program (Control)
Number of subjects: 984
Study: 19629314

Group type: EXPERIMENTAL
Intervention: Nursing consultation and telephone monitoring every 15 days of educational nature
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual medical care and monthly telephone monitoring of administrative and epidemiological nature (Control Group)
Number of subjects: 0
Study: 16469989

Group type: EXPERIMENTAL
Intervention: MSS milk (milk enriched with calcium from milk solids and tricalcium phosphate)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CON milk (milk enriched with calcium from concentrated milk)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: FOS milk (milk with added fructo‐oligosaccharides)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CPP milk (milk with added caseinophosphopeptides)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control milk (standard milk)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TCP added to MSS milk
Number of subjects: 15
Study: 12818982

Group type: EXPERIMENTAL
Intervention: Size 5 ProSeal laryngeal mask airway in men
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Size 5 ProSeal laryngeal mask airway in women
Number of subjects: 90

Group type: COMPARATOR
Intervention: Size 4 ProSeal laryngeal mask airway in women
Number of subjects: 90
Study: 10686210

Group type: EXPERIMENTAL
Intervention: Org 31710 (150 mg, every 28 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9139617

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis using an extracorporeal adsorption column containing dextran sulfate cellulose beads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis
Number of subjects: 0
Study: 1536625

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study: 6388305

Group type: EXPERIMENTAL
Intervention: Rice, Spaghetti, Lentil (as part of a conventional mixed meal providing 40% of caloric requirement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potato (as part of a conventional mixed meal providing 40% of caloric requirement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All carbohydrate sources tested (Rice, Spaghetti, Lentil, Potato)
Number of subjects: 0
Study: 31713710

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor/neprilysin inhibitor (ARNI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACEI/ARB
Number of subjects: 0
Study: 30802500

Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 28527546

Group type: EXPERIMENTAL
Intervention: Reflective blankets
Number of subjects: 328
Study: 25303070

Group type: EXPERIMENTAL
Intervention: Aquatic exercise (45 minutes, 3 times per week for 8 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no aquatic exercise, maintained normal treatments)
Number of subjects: 37
Study: 24050577

Group type: EXPERIMENTAL
Intervention: S. officinalis leaf extract (500 mg capsule t.i.d. for 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21483279

Group type: EXPERIMENTAL
Intervention: Mechanical lumbar traction with 50% of body weight
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mechanical lumbar traction with 10% of body weight
Number of subjects: 30
Study: 19008268

Group type: EXPERIMENTAL
Intervention: Percutaneous BCG (n=5775)
Number of subjects: 11680

Group type: COMPARATOR
Intervention: Intradermal BCG (n=5905)
Number of subjects: 11680

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 11680
Study: 16283370

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (INT) - 6-10x2 min at 120-140% LT with 1 min rest, 3 days per week for 5 weeks.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (CON) - 80-95% LT, 3 days per week for 5 weeks.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both INT and CON groups
Number of subjects: 16
Study: 12721238

Group type: EXPERIMENTAL
Intervention: Resistance exercise program (3 times per week for 12 weeks)
Number of subjects: 155
Study: 11753809

Group type: EXPERIMENTAL
Intervention: Octreoid-Depot 160 mg i.m. injection once a month plus 20 mg tamoxifen daily
Number of subjects: 263

Group type: COMPARATOR
Intervention: Tamoxifen plus placebo
Number of subjects: 263
Study: 9289303

Group type: EXPERIMENTAL
Intervention: Ever wheezers
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Wheezers in the last 12 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: Exercise challenge test
Number of subjects: 161
Study: 8388357

Group type: EXPERIMENTAL
Intervention: Logiparin (2,500 IU)
Number of subjects: 1290

Group type: EXPERIMENTAL
Intervention: Logiparin (3,500 IU)
Number of subjects: 1290

Group type: COMPARATOR
Intervention: UF heparin (2 x 5,000 IU)
Number of subjects: 1290
Study: 2879969

Group type: EXPERIMENTAL
Intervention: Olive oil diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complex carbohydrate diet
Number of subjects: 0
Study: 30192786

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (case management and behavioral activation)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 626
Study: 27658215

Group type: EXPERIMENTAL
Intervention: Nurse-led onsite mentoring program
Number of subjects: 108
Study: 24612686

Group type: EXPERIMENTAL
Intervention: 3D displays
Number of subjects: 15

Group type: COMPARATOR
Intervention: 2D displays
Number of subjects: 15
Study: 24024838

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 198

Group type: COMPARATOR
Intervention: 1.25 g testosterone gel daily
Number of subjects: 198

Group type: COMPARATOR
Intervention: 2.5 g testosterone gel daily
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 5 g testosterone gel daily
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 10 g testosterone gel daily
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Testosterone gel with anastrozole
Number of subjects: 198
Study: 21540740

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Applied Relaxation (AR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both conditions (ACT and AR)
Number of subjects: 90
Study: 18438830

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Denosumab 180 mg
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 16284225

Group type: EXPERIMENTAL
Intervention: Rowers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 30
Study: 14519177

Group type: EXPERIMENTAL
Intervention: Oral selegiline plus nicotine patch
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo plus nicotine patch
Number of subjects: 109
Study: 10714415

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 mcg b.d.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zafirlukast 20 mg b.d.
Number of subjects: 30
Study: 9185029

Group type: EXPERIMENTAL
Intervention: Indapamide 1.25 mg once daily for 8 weeks
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 204
Study: 7968325

Group type: EXPERIMENTAL
Intervention: Lumbar extradural morphine group (n = 35)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Caudal extradural morphine group (n = 35)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (n = 35)
Number of subjects: 105
Study: 3569631

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional treatment (CT) (2 to 3 injections/day, self blood glucose monitoring)
Number of subjects: 54
Study: 30354579

Group type: EXPERIMENTAL
Intervention: MINT-TLC intervention plus motivational interviewing
Number of subjects: 373

Group type: COMPARATOR
Intervention: HE control group
Number of subjects: 373
Study: 27433887

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) for childhood anxiety disorders
Number of subjects: 66
Study: 24793909

Group type: EXPERIMENTAL
Intervention: Improvers (⩾30% baseline to 2‐month reduction on the Insomnia Severity Index [ISI])
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Improvers
Number of subjects: 367
Study: 22763669

Group type: EXPERIMENTAL
Intervention: Low alcohol condition (BAC <0.05%) with low THC (1.8% THC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High alcohol condition (BAC >0.05%) with low THC (1.8% THC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High alcohol condition (BAC >0.05%) with high THC (3% THC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo cigarette (0% THC) with alcohol (not specified if low or high)
Number of subjects: 80
Study: 16045185

Group type: EXPERIMENTAL
Intervention: JWiTS regimen for Wilms tumor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New regimen for MRTK
Number of subjects: 0
Study: 12453257

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Not using oral contraceptives
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (male students)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tactile threshold (TT)
Number of subjects: 25
Study: 9843458

Group type: EXPERIMENTAL
Intervention: Streptokinase (1.5 million U)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alteplase (up to 100 mg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no thrombolytic therapy)
Number of subjects: 61
Study: 8593716

Group type: EXPERIMENTAL
Intervention: 200 micrograms/cm2 of sphinganine in ethanol (50 microliters of a 1.6% solution)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.5% sphingosine in ethanol-petrolatum ointment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.5% sphinganine in ethanol
Number of subjects: 0
Study: 2527675

Group type: EXPERIMENTAL
Intervention: Enprostil 35 micrograms thrice daily for two weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Enprostil
Number of subjects: 15
Study: 326688

Group type: EXPERIMENTAL
Intervention: 1-isopropyl-4-phenyl-7-methyl-2 (1H) quinazolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31169568

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg 4 times a day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Gabapentin (300 mg 4 times a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study: 29797155

Group type: EXPERIMENTAL
Intervention: SMR up-training/Theta down-training (SMR⇑Theta⇓)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Theta up-training/SMR down-training (Theta⇑SMR⇓)
Number of subjects: 30
Study: 26306603

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich drink
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Protein-enriched drink
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (Carbohydrate-rich drink, Protein-enriched drink, Tap water)
Number of subjects: 90
Study: 25525519

Group type: EXPERIMENTAL
Intervention: Continuous use of Entonox
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intermittent use of Entonox
Number of subjects: 100
Study: 22706930

Group type: EXPERIMENTAL
Intervention: Online Spaced Education (SE) programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online slide show followed by a quiz (SQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online Spaced Education (SE) programme among surgical interns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online slide show followed by a quiz (SQ) among surgical interns
Number of subjects: 0
Study: 19775203

Group type: EXPERIMENTAL
Intervention: Saracatinib (250 mg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59